FBXO10 and nasopharyngeal carcinoma: The acetylation of ACSL4 could inhibit FBXO10-mediated K48-linked ubiquitination, resulting in enhanced protein stability of ACSL4, thereby promoting the double-edged sword effect: malignant progression and ferroptosis of NPC cells (Fig. 10).